0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Somatostatin for Injection Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-13M13761
Home | Market Reports | Science| Biological Sciences
Global Somatostatin for Injection Market Research Report 2023
BUY CHAPTERS

Global Somatostatin for Injection Market Research Report 2024

Code: QYRE-Auto-13M13761
Report
August 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Somatostatin for Injection Market

Somatostatin for injection is a synthetic cyclic fourteen amino acid, which is exactly the same as natural growth hormone in chemical structure and action. By intravenous injection, somatostatin inhibits the secretion of growth hormone, thyroid-stimulating hormone, insulin, and glucagon, and suppresses the secretion of gastric acid. It also affects absorption, motility, splanchnic blood flow, and nutritional function of the gastrointestinal tract.
The global Somatostatin for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Somatostatin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Somatostatin for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Somatostatin for Injection include Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited, Eumedica, Merck, Sanofi, PolyPeptide Group and Samarth Life Sciences Pvt, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Somatostatin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatostatin for Injection.

Report Scope

The Somatostatin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Somatostatin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Somatostatin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Somatostatin for Injection Market Report

Report Metric Details
Report Name Somatostatin for Injection Market
Segment by Type
  • 1mg/Vial
  • 3mg/Vial
  • Others
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited, Eumedica, Merck, Sanofi, PolyPeptide Group, Samarth Life Sciences Pvt, Hybio Pharmaceutical, Yangtze River Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, Hainan Zhonghe Pharmaceutical, Wuhan Hualong, Qingdao Guoda, Chengdu Shengnuo, Kumming Longjin Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Somatostatin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Somatostatin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Somatostatin for Injection Market report?

Ans: The main players in the Somatostatin for Injection Market are Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited, Eumedica, Merck, Sanofi, PolyPeptide Group, Samarth Life Sciences Pvt, Hybio Pharmaceutical, Yangtze River Pharmaceutical, Hainan Shuangcheng Pharmaceuticals, Hainan Zhonghe Pharmaceutical, Wuhan Hualong, Qingdao Guoda, Chengdu Shengnuo, Kumming Longjin Pharmaceutical

What are the Application segmentation covered in the Somatostatin for Injection Market report?

Ans: The Applications covered in the Somatostatin for Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Somatostatin for Injection Market report?

Ans: The Types covered in the Somatostatin for Injection Market report are 1mg/Vial, 3mg/Vial, Others

Recommended Reports

Somatostatin & Analogs

Hormonal Injections

Neuroendocrine and Peptide Therapies

1 Somatostatin for Injection Market Overview
1.1 Product Overview and Scope of Somatostatin for Injection
1.2 Somatostatin for Injection Segment by Type
1.2.1 Global Somatostatin for Injection Market Value Comparison by Type (2024-2030)
1.2.2 1mg/Vial
1.2.3 3mg/Vial
1.2.4 Others
1.3 Somatostatin for Injection Segment by Application
1.3.1 Global Somatostatin for Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Somatostatin for Injection Market Size Estimates and Forecasts
1.4.1 Global Somatostatin for Injection Revenue 2019-2030
1.4.2 Global Somatostatin for Injection Sales 2019-2030
1.4.3 Global Somatostatin for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Somatostatin for Injection Market Competition by Manufacturers
2.1 Global Somatostatin for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Somatostatin for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Somatostatin for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Somatostatin for Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Somatostatin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Somatostatin for Injection, Product Type & Application
2.7 Somatostatin for Injection Market Competitive Situation and Trends
2.7.1 Somatostatin for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Somatostatin for Injection Players Market Share by Revenue
2.7.3 Global Somatostatin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Somatostatin for Injection Retrospective Market Scenario by Region
3.1 Global Somatostatin for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Somatostatin for Injection Global Somatostatin for Injection Sales by Region: 2019-2030
3.2.1 Global Somatostatin for Injection Sales by Region: 2019-2024
3.2.2 Global Somatostatin for Injection Sales by Region: 2025-2030
3.3 Global Somatostatin for Injection Global Somatostatin for Injection Revenue by Region: 2019-2030
3.3.1 Global Somatostatin for Injection Revenue by Region: 2019-2024
3.3.2 Global Somatostatin for Injection Revenue by Region: 2025-2030
3.4 North America Somatostatin for Injection Market Facts & Figures by Country
3.4.1 North America Somatostatin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Somatostatin for Injection Sales by Country (2019-2030)
3.4.3 North America Somatostatin for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Somatostatin for Injection Market Facts & Figures by Country
3.5.1 Europe Somatostatin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Somatostatin for Injection Sales by Country (2019-2030)
3.5.3 Europe Somatostatin for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Somatostatin for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Somatostatin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Somatostatin for Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Somatostatin for Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Somatostatin for Injection Market Facts & Figures by Country
3.7.1 Latin America Somatostatin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Somatostatin for Injection Sales by Country (2019-2030)
3.7.3 Latin America Somatostatin for Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Somatostatin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Somatostatin for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Somatostatin for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Somatostatin for Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Somatostatin for Injection Sales by Type (2019-2030)
4.1.1 Global Somatostatin for Injection Sales by Type (2019-2024)
4.1.2 Global Somatostatin for Injection Sales by Type (2025-2030)
4.1.3 Global Somatostatin for Injection Sales Market Share by Type (2019-2030)
4.2 Global Somatostatin for Injection Revenue by Type (2019-2030)
4.2.1 Global Somatostatin for Injection Revenue by Type (2019-2024)
4.2.2 Global Somatostatin for Injection Revenue by Type (2025-2030)
4.2.3 Global Somatostatin for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Somatostatin for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Somatostatin for Injection Sales by Application (2019-2030)
5.1.1 Global Somatostatin for Injection Sales by Application (2019-2024)
5.1.2 Global Somatostatin for Injection Sales by Application (2025-2030)
5.1.3 Global Somatostatin for Injection Sales Market Share by Application (2019-2030)
5.2 Global Somatostatin for Injection Revenue by Application (2019-2030)
5.2.1 Global Somatostatin for Injection Revenue by Application (2019-2024)
5.2.2 Global Somatostatin for Injection Revenue by Application (2025-2030)
5.2.3 Global Somatostatin for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Somatostatin for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biocon
6.1.1 Biocon Corporation Information
6.1.2 Biocon Description and Business Overview
6.1.3 Biocon Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biocon Somatostatin for Injection Product Portfolio
6.1.5 Biocon Recent Developments/Updates
6.2 Ferring Pharmaceuticals
6.2.1 Ferring Pharmaceuticals Corporation Information
6.2.2 Ferring Pharmaceuticals Description and Business Overview
6.2.3 Ferring Pharmaceuticals Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ferring Pharmaceuticals Somatostatin for Injection Product Portfolio
6.2.5 Ferring Pharmaceuticals Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute of India Somatostatin for Injection Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 UCB India Private Limited
6.4.1 UCB India Private Limited Corporation Information
6.4.2 UCB India Private Limited Description and Business Overview
6.4.3 UCB India Private Limited Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB India Private Limited Somatostatin for Injection Product Portfolio
6.4.5 UCB India Private Limited Recent Developments/Updates
6.5 Eumedica
6.5.1 Eumedica Corporation Information
6.5.2 Eumedica Description and Business Overview
6.5.3 Eumedica Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eumedica Somatostatin for Injection Product Portfolio
6.5.5 Eumedica Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck Somatostatin for Injection Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Somatostatin for Injection Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 PolyPeptide Group
6.8.1 PolyPeptide Group Corporation Information
6.8.2 PolyPeptide Group Description and Business Overview
6.8.3 PolyPeptide Group Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PolyPeptide Group Somatostatin for Injection Product Portfolio
6.8.5 PolyPeptide Group Recent Developments/Updates
6.9 Samarth Life Sciences Pvt
6.9.1 Samarth Life Sciences Pvt Corporation Information
6.9.2 Samarth Life Sciences Pvt Description and Business Overview
6.9.3 Samarth Life Sciences Pvt Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Samarth Life Sciences Pvt Somatostatin for Injection Product Portfolio
6.9.5 Samarth Life Sciences Pvt Recent Developments/Updates
6.10 Hybio Pharmaceutical
6.10.1 Hybio Pharmaceutical Corporation Information
6.10.2 Hybio Pharmaceutical Description and Business Overview
6.10.3 Hybio Pharmaceutical Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hybio Pharmaceutical Somatostatin for Injection Product Portfolio
6.10.5 Hybio Pharmaceutical Recent Developments/Updates
6.11 Yangtze River Pharmaceutical
6.11.1 Yangtze River Pharmaceutical Corporation Information
6.11.2 Yangtze River Pharmaceutical Somatostatin for Injection Description and Business Overview
6.11.3 Yangtze River Pharmaceutical Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yangtze River Pharmaceutical Somatostatin for Injection Product Portfolio
6.11.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.12 Hainan Shuangcheng Pharmaceuticals
6.12.1 Hainan Shuangcheng Pharmaceuticals Corporation Information
6.12.2 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Description and Business Overview
6.12.3 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product Portfolio
6.12.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
6.13 Hainan Zhonghe Pharmaceutical
6.13.1 Hainan Zhonghe Pharmaceutical Corporation Information
6.13.2 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Description and Business Overview
6.13.3 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product Portfolio
6.13.5 Hainan Zhonghe Pharmaceutical Recent Developments/Updates
6.14 Wuhan Hualong
6.14.1 Wuhan Hualong Corporation Information
6.14.2 Wuhan Hualong Somatostatin for Injection Description and Business Overview
6.14.3 Wuhan Hualong Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Wuhan Hualong Somatostatin for Injection Product Portfolio
6.14.5 Wuhan Hualong Recent Developments/Updates
6.15 Qingdao Guoda
6.15.1 Qingdao Guoda Corporation Information
6.15.2 Qingdao Guoda Somatostatin for Injection Description and Business Overview
6.15.3 Qingdao Guoda Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Qingdao Guoda Somatostatin for Injection Product Portfolio
6.15.5 Qingdao Guoda Recent Developments/Updates
6.16 Chengdu Shengnuo
6.16.1 Chengdu Shengnuo Corporation Information
6.16.2 Chengdu Shengnuo Somatostatin for Injection Description and Business Overview
6.16.3 Chengdu Shengnuo Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Chengdu Shengnuo Somatostatin for Injection Product Portfolio
6.16.5 Chengdu Shengnuo Recent Developments/Updates
6.17 Kumming Longjin Pharmaceutical
6.17.1 Kumming Longjin Pharmaceutical Corporation Information
6.17.2 Kumming Longjin Pharmaceutical Somatostatin for Injection Description and Business Overview
6.17.3 Kumming Longjin Pharmaceutical Somatostatin for Injection Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Kumming Longjin Pharmaceutical Somatostatin for Injection Product Portfolio
6.17.5 Kumming Longjin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Somatostatin for Injection Industry Chain Analysis
7.2 Somatostatin for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Somatostatin for Injection Production Mode & Process
7.4 Somatostatin for Injection Sales and Marketing
7.4.1 Somatostatin for Injection Sales Channels
7.4.2 Somatostatin for Injection Distributors
7.5 Somatostatin for Injection Customers
8 Somatostatin for Injection Market Dynamics
8.1 Somatostatin for Injection Industry Trends
8.2 Somatostatin for Injection Market Drivers
8.3 Somatostatin for Injection Market Challenges
8.4 Somatostatin for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Somatostatin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Somatostatin for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Somatostatin for Injection Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Somatostatin for Injection Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Somatostatin for Injection Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Somatostatin for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Somatostatin for Injection Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Somatostatin for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Somatostatin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Somatostatin for Injection, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Somatostatin for Injection, Product Type & Application
    Table 12. Global Key Manufacturers of Somatostatin for Injection, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Somatostatin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin for Injection as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Somatostatin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Somatostatin for Injection Sales by Region (2019-2024) & (K Units)
    Table 18. Global Somatostatin for Injection Sales Market Share by Region (2019-2024)
    Table 19. Global Somatostatin for Injection Sales by Region (2025-2030) & (K Units)
    Table 20. Global Somatostatin for Injection Sales Market Share by Region (2025-2030)
    Table 21. Global Somatostatin for Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Somatostatin for Injection Revenue Market Share by Region (2019-2024)
    Table 23. Global Somatostatin for Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Somatostatin for Injection Revenue Market Share by Region (2025-2030)
    Table 25. North America Somatostatin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Somatostatin for Injection Sales by Country (2019-2024) & (K Units)
    Table 27. North America Somatostatin for Injection Sales by Country (2025-2030) & (K Units)
    Table 28. North America Somatostatin for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Somatostatin for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Somatostatin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Somatostatin for Injection Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Somatostatin for Injection Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Somatostatin for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Somatostatin for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Somatostatin for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Somatostatin for Injection Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Somatostatin for Injection Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Somatostatin for Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Somatostatin for Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Somatostatin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Somatostatin for Injection Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Somatostatin for Injection Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Somatostatin for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Somatostatin for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Somatostatin for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Somatostatin for Injection Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Somatostatin for Injection Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Somatostatin for Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Somatostatin for Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Somatostatin for Injection Sales (K Units) by Type (2019-2024)
    Table 51. Global Somatostatin for Injection Sales (K Units) by Type (2025-2030)
    Table 52. Global Somatostatin for Injection Sales Market Share by Type (2019-2024)
    Table 53. Global Somatostatin for Injection Sales Market Share by Type (2025-2030)
    Table 54. Global Somatostatin for Injection Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Somatostatin for Injection Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Somatostatin for Injection Revenue Market Share by Type (2019-2024)
    Table 57. Global Somatostatin for Injection Revenue Market Share by Type (2025-2030)
    Table 58. Global Somatostatin for Injection Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Somatostatin for Injection Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Somatostatin for Injection Sales (K Units) by Application (2019-2024)
    Table 61. Global Somatostatin for Injection Sales (K Units) by Application (2025-2030)
    Table 62. Global Somatostatin for Injection Sales Market Share by Application (2019-2024)
    Table 63. Global Somatostatin for Injection Sales Market Share by Application (2025-2030)
    Table 64. Global Somatostatin for Injection Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Somatostatin for Injection Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Somatostatin for Injection Revenue Market Share by Application (2019-2024)
    Table 67. Global Somatostatin for Injection Revenue Market Share by Application (2025-2030)
    Table 68. Global Somatostatin for Injection Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Somatostatin for Injection Price (US$/Unit) by Application (2025-2030)
    Table 70. Biocon Corporation Information
    Table 71. Biocon Description and Business Overview
    Table 72. Biocon Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Biocon Somatostatin for Injection Product
    Table 74. Biocon Recent Developments/Updates
    Table 75. Ferring Pharmaceuticals Corporation Information
    Table 76. Ferring Pharmaceuticals Description and Business Overview
    Table 77. Ferring Pharmaceuticals Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Ferring Pharmaceuticals Somatostatin for Injection Product
    Table 79. Ferring Pharmaceuticals Recent Developments/Updates
    Table 80. Serum Institute of India Corporation Information
    Table 81. Serum Institute of India Description and Business Overview
    Table 82. Serum Institute of India Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Serum Institute of India Somatostatin for Injection Product
    Table 84. Serum Institute of India Recent Developments/Updates
    Table 85. UCB India Private Limited Corporation Information
    Table 86. UCB India Private Limited Description and Business Overview
    Table 87. UCB India Private Limited Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. UCB India Private Limited Somatostatin for Injection Product
    Table 89. UCB India Private Limited Recent Developments/Updates
    Table 90. Eumedica Corporation Information
    Table 91. Eumedica Description and Business Overview
    Table 92. Eumedica Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Eumedica Somatostatin for Injection Product
    Table 94. Eumedica Recent Developments/Updates
    Table 95. Merck Corporation Information
    Table 96. Merck Description and Business Overview
    Table 97. Merck Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Merck Somatostatin for Injection Product
    Table 99. Merck Recent Developments/Updates
    Table 100. Sanofi Corporation Information
    Table 101. Sanofi Description and Business Overview
    Table 102. Sanofi Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Sanofi Somatostatin for Injection Product
    Table 104. Sanofi Recent Developments/Updates
    Table 105. PolyPeptide Group Corporation Information
    Table 106. PolyPeptide Group Description and Business Overview
    Table 107. PolyPeptide Group Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. PolyPeptide Group Somatostatin for Injection Product
    Table 109. PolyPeptide Group Recent Developments/Updates
    Table 110. Samarth Life Sciences Pvt Corporation Information
    Table 111. Samarth Life Sciences Pvt Description and Business Overview
    Table 112. Samarth Life Sciences Pvt Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Samarth Life Sciences Pvt Somatostatin for Injection Product
    Table 114. Samarth Life Sciences Pvt Recent Developments/Updates
    Table 115. Hybio Pharmaceutical Corporation Information
    Table 116. Hybio Pharmaceutical Description and Business Overview
    Table 117. Hybio Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Hybio Pharmaceutical Somatostatin for Injection Product
    Table 119. Hybio Pharmaceutical Recent Developments/Updates
    Table 120. Yangtze River Pharmaceutical Corporation Information
    Table 121. Yangtze River Pharmaceutical Description and Business Overview
    Table 122. Yangtze River Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Yangtze River Pharmaceutical Somatostatin for Injection Product
    Table 124. Yangtze River Pharmaceutical Recent Developments/Updates
    Table 125. Hainan Shuangcheng Pharmaceuticals Corporation Information
    Table 126. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
    Table 127. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product
    Table 129. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
    Table 130. Hainan Zhonghe Pharmaceutical Corporation Information
    Table 131. Hainan Zhonghe Pharmaceutical Description and Business Overview
    Table 132. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product
    Table 134. Hainan Zhonghe Pharmaceutical Recent Developments/Updates
    Table 135. Wuhan Hualong Corporation Information
    Table 136. Wuhan Hualong Description and Business Overview
    Table 137. Wuhan Hualong Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Wuhan Hualong Somatostatin for Injection Product
    Table 139. Wuhan Hualong Recent Developments/Updates
    Table 140. Qingdao Guoda Corporation Information
    Table 141. Qingdao Guoda Description and Business Overview
    Table 142. Qingdao Guoda Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Qingdao Guoda Somatostatin for Injection Product
    Table 144. Qingdao Guoda Recent Developments/Updates
    Table 145. Chengdu Shengnuo Corporation Information
    Table 146. Chengdu Shengnuo Description and Business Overview
    Table 147. Chengdu Shengnuo Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Chengdu Shengnuo Somatostatin for Injection Product
    Table 149. Chengdu Shengnuo Recent Developments/Updates
    Table 150. Kumming Longjin Pharmaceutical Corporation Information
    Table 151. Kumming Longjin Pharmaceutical Description and Business Overview
    Table 152. Kumming Longjin Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Kumming Longjin Pharmaceutical Somatostatin for Injection Product
    Table 154. Kumming Longjin Pharmaceutical Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Somatostatin for Injection Distributors List
    Table 158. Somatostatin for Injection Customers List
    Table 159. Somatostatin for Injection Market Trends
    Table 160. Somatostatin for Injection Market Drivers
    Table 161. Somatostatin for Injection Market Challenges
    Table 162. Somatostatin for Injection Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Somatostatin for Injection
    Figure 2. Global Somatostatin for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Somatostatin for Injection Market Share by Type in 2023 & 2030
    Figure 4. 1mg/Vial Product Picture
    Figure 5. 3mg/Vial Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Somatostatin for Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Somatostatin for Injection Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Clinic
    Figure 11. Global Somatostatin for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Somatostatin for Injection Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Somatostatin for Injection Sales (2019-2030) & (K Units)
    Figure 14. Global Somatostatin for Injection Average Price (US$/Unit) & (2019-2030)
    Figure 15. Somatostatin for Injection Report Years Considered
    Figure 16. Somatostatin for Injection Sales Share by Manufacturers in 2023
    Figure 17. Global Somatostatin for Injection Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Somatostatin for Injection Players: Market Share by Revenue in 2023
    Figure 19. Somatostatin for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Somatostatin for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Somatostatin for Injection Sales Market Share by Country (2019-2030)
    Figure 22. North America Somatostatin for Injection Revenue Market Share by Country (2019-2030)
    Figure 23. United States Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Somatostatin for Injection Sales Market Share by Country (2019-2030)
    Figure 26. Europe Somatostatin for Injection Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Somatostatin for Injection Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Somatostatin for Injection Revenue Market Share by Region (2019-2030)
    Figure 34. China Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Somatostatin for Injection Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Somatostatin for Injection Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Somatostatin for Injection Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Somatostatin for Injection Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Somatostatin for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Somatostatin for Injection by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Somatostatin for Injection by Type (2019-2030)
    Figure 55. Global Somatostatin for Injection Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Somatostatin for Injection by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Somatostatin for Injection by Application (2019-2030)
    Figure 58. Global Somatostatin for Injection Price (US$/Unit) by Application (2019-2030)
    Figure 59. Somatostatin for Injection Value Chain
    Figure 60. Somatostatin for Injection Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart